BioCardia, Inc.

NasdaqCM:BCDA Stock Report

Market Cap: US$9.0m

BioCardia Management

Management criteria checks 4/4

BioCardia's CEO is Peter Altman, appointed in Jan 2002, has a tenure of 22.92 years. total yearly compensation is $746.24K, comprised of 69.1% salary and 30.9% bonuses, including company stock and options. directly owns 2.3% of the company’s shares, worth $207.99K. The average tenure of the management team and the board of directors is 8.8 years and 8.2 years respectively.

Key information

Peter Altman

Chief executive officer

US$746.2k

Total compensation

CEO salary percentage69.1%
CEO tenure22.9yrs
CEO ownership2.3%
Management average tenure8.8yrs
Board average tenure8.2yrs

Recent management updates

Most Shareholders Will Probably Find That The Compensation For BioCardia, Inc.'s (NASDAQ:BCDA) CEO Is Reasonable

May 14
Most Shareholders Will Probably Find That The Compensation For BioCardia, Inc.'s (NASDAQ:BCDA) CEO Is Reasonable

Here's Why BioCardia, Inc.'s (NASDAQ:BCDA) CEO Compensation Is The Least Of Shareholders Concerns

Oct 12
Here's Why BioCardia, Inc.'s (NASDAQ:BCDA) CEO Compensation Is The Least Of Shareholders Concerns

Recent updates

Most Shareholders Will Probably Find That The Compensation For BioCardia, Inc.'s (NASDAQ:BCDA) CEO Is Reasonable

May 14
Most Shareholders Will Probably Find That The Compensation For BioCardia, Inc.'s (NASDAQ:BCDA) CEO Is Reasonable

Here's Why BioCardia, Inc.'s (NASDAQ:BCDA) CEO Compensation Is The Least Of Shareholders Concerns

Oct 12
Here's Why BioCardia, Inc.'s (NASDAQ:BCDA) CEO Compensation Is The Least Of Shareholders Concerns

BioCardia stock rises on contract for delivery products for BlueRock's cell therapies

Aug 24

Will BioCardia (NASDAQ:BCDA) Spend Its Cash Wisely?

Aug 24
Will BioCardia (NASDAQ:BCDA) Spend Its Cash Wisely?

Here's Why We're Watching BioCardia's (NASDAQ:BCDA) Cash Burn Situation

May 10
Here's Why We're Watching BioCardia's (NASDAQ:BCDA) Cash Burn Situation

We Think BioCardia (NASDAQ:BCDA) Needs To Drive Business Growth Carefully

Jan 06
We Think BioCardia (NASDAQ:BCDA) Needs To Drive Business Growth Carefully

We Think BioCardia (NASDAQ:BCDA) Needs To Drive Business Growth Carefully

Sep 23
We Think BioCardia (NASDAQ:BCDA) Needs To Drive Business Growth Carefully

CEO Compensation Analysis

How has Peter Altman's remuneration changed compared to BioCardia's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$8m

Jun 30 2024n/an/a

-US$9m

Mar 31 2024n/an/a

-US$10m

Dec 31 2023US$746kUS$516k

-US$12m

Sep 30 2023n/an/a

-US$13m

Jun 30 2023n/an/a

-US$13m

Mar 31 2023n/an/a

-US$12m

Dec 31 2022US$902kUS$531k

-US$12m

Sep 30 2022n/an/a

-US$12m

Jun 30 2022n/an/a

-US$12m

Mar 31 2022n/an/a

-US$13m

Dec 31 2021US$1mUS$488k

-US$13m

Sep 30 2021n/an/a

-US$12m

Jun 30 2021n/an/a

-US$13m

Mar 31 2021n/an/a

-US$13m

Dec 31 2020US$883kUS$380k

-US$15m

Sep 30 2020n/an/a

-US$16m

Jun 30 2020n/an/a

-US$15m

Mar 31 2020n/an/a

-US$16m

Dec 31 2019US$747kUS$363k

-US$15m

Sep 30 2019n/an/a

-US$15m

Jun 30 2019n/an/a

-US$15m

Mar 31 2019n/an/a

-US$14m

Dec 31 2018US$1mUS$360k

-US$14m

Sep 30 2018n/an/a

-US$14m

Jun 30 2018n/an/a

-US$13m

Mar 31 2018n/an/a

-US$13m

Dec 31 2017US$372kUS$310k

-US$12m

Compensation vs Market: Peter's total compensation ($USD746.24K) is about average for companies of similar size in the US market ($USD653.16K).

Compensation vs Earnings: Peter's compensation has been consistent with company performance over the past year.

CEO

Peter Altman (57 yo)

22.9yrs

Tenure

US$746,237

Compensation

Dr. Peter A. Altman, Ph.D. has been Chief Executive Officer and President of BioCardia, Inc. since 2002. Dr. Altman served as an acting Chief Executive Officer of Lumen Therapeutics from 2004 to 2005. He s...

Leadership Team

NamePositionTenureCompensationOwnership
Peter Altman
CEO, President & Director22.9yrsUS$746.24k2.3%
$ 208.0k
David McClung
Chief Financial Officer8.8yrsUS$469.47k0.65%
$ 59.1k
Edward Gillis
Senior Vice President of Devices4.2yrsUS$326.37k0.27%
$ 24.1k

8.8yrs

Average Tenure

61yo

Average Age

Experienced Management: BCDA's management team is seasoned and experienced (8.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Peter Altman
CEO, President & Director22.9yrsUS$746.24k2.3%
$ 208.0k
Jay Moyes
Independent Director13.9yrsUS$65.29k0.079%
$ 7.1k
Richard Krasno
Independent Director8.2yrsUS$57.79k0.069%
$ 6.2k
William Facteau
Independent Director1.2yrsUS$24.69kno data
Simon Stertzer
Independent Director22.9yrsUS$47.55k2.17%
$ 195.7k
Jim Allen
Independent Director5.2yrsUS$49.29k2.39%
$ 216.1k
Andrew Blank
Independent Chairman5.2yrsUS$97.79k3.15%
$ 284.7k

8.2yrs

Average Tenure

69yo

Average Age

Experienced Board: BCDA's board of directors are considered experienced (8.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 12:04
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BioCardia, Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joseph PantginisH.C. Wainwright & Co.
Emanuela BranchettiH.C. Wainwright & Co.